CCI4EU - Clinical trials and clinical research
MATERIALS AVAILABLE
CCI4EU - Clinical trials and clinical research
MATERIALS AVAILABLE
This course is the second of 10 online training courses organised within the project to help countries develop an effective comprehensive infrastructure and widen the reach of this grant. The topic of this online course is: Clinical Trials and Clinical Research.
The aim is to discover how to build a successful and sustainable clinical research programme.
The first part of this course was made available on this website from 16 September 2024.
The second part of this online course was held live on 15 October 2024 via this webpage. The entire course was recorded and is now available as on-demand material.
To access the on-demand materials (after the live streaming), participants must register to the course, login to the e-ESO platform and click on the play buttons inside the course programme.
Certificate of attendance
Organising secretariat
Francesca Marangoni: fmarangoni@eso.net
Sonia Bulgarelli: sbulgarelli@eso.net
PART 1: How to make clinical research balanced between academia and pharma-sponsored?
Academic studies/commercial, which is the right proportion? - common cancers
Richard Baird (UK)Academic studies/commercial, which is the right proportion? - rare cancers
Silvia Stacchiotti (IT)How multidisciplinary tasks forces contribute to foster translational research
Alejandro Piris (ES)PART 2: Clinical Research as a Fundamental Pillar of CCIs: innovation, quality control, sustainability, outcomes and PROs
How do you build your network? Euracan ERN as a model
Jean-Yves Blay (FR)How to initiate and conduct clinical trials in Europe? Protarget Study as a model trial for precision oncology
Ulrik Lassen (DK)How to manage the usage of medical data? Step forward to data federation based on IDEA4RC project
Annalisa Trama (IT)PART 3: How to navigate the threats for clinical research in Europe?
How to harmonise the processes for assessment and supervision of clinical trials throughout the EU? The pros and cons of the EU CTR
Scott Greenfeder (US)How does IVDR affect clinical research in Europe?
Dario Trapani (IT)How do you conduct/finance academic studies with a molecular pre-screening programme and drug supply?
Carlos Lopez (ES)LIVE STREAMING
Introduction and welcome
PART 1: How to make clinical research balanced between academia and pharma-sponsored?
Summary
Josep Tabernero (ES)PART 2: Clinical Research as a Fundamental Pillar of CCIs: innovation, quality control, sustainability, outcomes and PROs
Summary
Iwona Lugowska (PL)PART 3: How to navigate the threats for clinical research in Europe?
Summary
Josep Tabernero (ES)PART 4: Example cases
Western Europe experience
Maud Kamal (FR)Eastern Europe experience
Piotr Rutkowski (PL)Take home message and closing remarks
Alejandro Piris
Vall Hebron Institute of Oncology, Scientific Coordination Area, Barcelona, ES
Ana Zanoletty
, , ,
Annalisa Trama
National Cancer Institute - IRCCS Foundation, ., Milano, IT
Carlos Lopez
Vall d’Hebron Institute of Oncology, Business Development Dpt., Barcelona, ES
Dario Trapani
European Institute of Oncology, Early Clinical Trial Division, Milan, IT
Elena Garralda
VHIO – Vall d’Hebron Institute of Oncology, , Barcelona, ES
Francesco Pignatti
European Medicines Agency, Scientific & Regulatory Management Department Oncology, Haematology & Diagnostics, London, UK
Iwona Lugowska
MSC Nationa Research Institute of Oncology, Early Phase Clinical Trials Unit, Warsaw, PL
Jan-Willem van de Loo
European Commission, RTD, Brussels, BE
Jean-Yves Blay
University Claude Bernard Lyon I, Centre Léon Bérard, Dept. of Medicine, Lyon, FR
Josep Tabernero
Vall d'Hebron University Hospital, Dept. of Medical Oncology, Barcelona, ES
Maud Kamal
Gustave Roussy Hospital, Scientific Manager Department, Villejuif, FR
Mef Nilbert
Lund University, Dept. Oncology, Institute for Clinical Sciences, Lund, SE
Piotr Rutkowski
Maria Sklodowska-Curie National Research Institute of Oncology, Dept. of Soft Tissue/Bone & Melanoma, Warszawa, PL
Rachel Giles
International Kidney Cancer Coalition (IKCC) & University Medical Center Utrecht, Nephrology Dpt., Duivendrecht, NL
Richard Baird
University of Cambridge, Cancer Research UK Cambridge Centre, Cambridge, United Kingdom
Scott Greenfeder
, , ,
Silvia Stacchiotti
Unità Sarcomi, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
Ulrik Lassen
Finsen Center-Rigshospitalet, Dept. of Oncology 5074, Copenhagen, DK
Winette van der Graaf
, , ,
Funded by:
